• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性黑素瘤中的溶酶体:生物学、功能和治疗应用。

The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications.

机构信息

Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan.

Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.

出版信息

Cells. 2022 Apr 29;11(9):1492. doi: 10.3390/cells11091492.

DOI:10.3390/cells11091492
PMID:35563798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9103375/
Abstract

Lysosomes are membrane-bound vesicles that play roles in the degradation and recycling of cellular waste and homeostasis maintenance within cells. False alterations of lysosomal functions can lead to broad detrimental effects and cause various diseases, including cancers. Cancer cells that are rapidly proliferative and invasive are highly dependent on effective lysosomal function. Malignant melanoma is the most lethal form of skin cancer, with high metastasis characteristics, drug resistance, and aggressiveness. It is critical to understand the role of lysosomes in melanoma pathogenesis in order to improve the outcomes of melanoma patients. In this mini-review, we compile our current knowledge of lysosomes' role in tumorigenesis, progression, therapy resistance, and the current treatment strategies related to lysosomes in melanoma.

摘要

溶酶体是一种具有膜结构的囊泡,在细胞内废物的降解和再循环以及维持细胞内环境稳定方面发挥着重要作用。溶酶体功能的错误改变会导致广泛的有害影响,并引发各种疾病,包括癌症。快速增殖和侵袭的癌细胞高度依赖于有效的溶酶体功能。恶性黑色素瘤是最致命的皮肤癌形式,具有高转移特性、耐药性和侵袭性。了解溶酶体在黑色素瘤发病机制中的作用对于改善黑色素瘤患者的预后至关重要。在这篇小型综述中,我们总结了目前关于溶酶体在肿瘤发生、进展、治疗耐药性以及与黑色素瘤相关的溶酶体治疗策略方面的作用的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1548/9103375/34d4935202e2/cells-11-01492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1548/9103375/34d4935202e2/cells-11-01492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1548/9103375/34d4935202e2/cells-11-01492-g001.jpg

相似文献

1
The Lysosome in Malignant Melanoma: Biology, Function and Therapeutic Applications.恶性黑素瘤中的溶酶体:生物学、功能和治疗应用。
Cells. 2022 Apr 29;11(9):1492. doi: 10.3390/cells11091492.
2
Lysosomal Function and Intracellular Position Determine the Malignant Phenotype in Malignant Melanoma.溶酶体功能和细胞内位置决定恶性黑色素瘤的恶性表型。
J Invest Dermatol. 2023 Sep;143(9):1769-1778.e12. doi: 10.1016/j.jid.2023.01.036. Epub 2023 Mar 4.
3
Lysosome biogenesis: Regulation and functions.溶酶体生物发生:调控与功能。
J Cell Biol. 2021 Jun 7;220(6). doi: 10.1083/jcb.202102001. Epub 2021 May 5.
4
Altered endosomal-lysosomal biogenesis in melanoma.黑素瘤中内体-溶酶体生物发生的改变。
Neoplasia. 2023 Sep;43:100924. doi: 10.1016/j.neo.2023.100924. Epub 2023 Aug 9.
5
Current methods to analyze lysosome morphology, positioning, motility and function.目前分析溶酶体形态、定位、运动和功能的方法。
Traffic. 2022 May;23(5):238-269. doi: 10.1111/tra.12839. Epub 2022 Apr 24.
6
Critical Functions of the Lysosome in Cancer Biology.溶酶体在癌症生物学中的关键功能。
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:481-507. doi: 10.1146/annurev-pharmtox-010715-103101. Epub 2016 Oct 12.
7
The lysosome: from waste bag to potential therapeutic target.溶酶体:从垃圾袋到潜在治疗靶点。
J Mol Cell Biol. 2013 Aug;5(4):214-26. doi: 10.1093/jmcb/mjt022.
8
Targeting the lysosome in cancer.靶向癌症中的溶酶体。
Ann N Y Acad Sci. 2016 May;1371(1):45-54. doi: 10.1111/nyas.12953. Epub 2015 Nov 24.
9
Lysosomes as dynamic regulators of cell and organismal homeostasis.溶酶体作为细胞和整体内稳态的动态调节剂。
Nat Rev Mol Cell Biol. 2020 Feb;21(2):101-118. doi: 10.1038/s41580-019-0185-4. Epub 2019 Nov 25.
10
Lysosome motility and distribution: Relevance in health and disease.溶酶体运动和分布:与健康和疾病的相关性。
Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1076-1087. doi: 10.1016/j.bbadis.2019.03.009. Epub 2019 Mar 21.

引用本文的文献

1
Lysosome-dependent cell death: disease implications and potential therapeutic targets.溶酶体依赖性细胞死亡:疾病影响及潜在治疗靶点
Mol Biol Rep. 2025 Sep 10;52(1):881. doi: 10.1007/s11033-025-10997-z.
2
Spatiotemporal Profiling Defines Persistence and Resistance Dynamics during Targeted Treatment of Melanoma.时空分析确定黑色素瘤靶向治疗期间的持久性和耐药动态。
Cancer Res. 2025 Mar 3;85(5):987-1002. doi: 10.1158/0008-5472.CAN-24-0690.
3
Targeting the organelle for radiosensitization in cancer radiotherapy.在癌症放射治疗中靶向细胞器以实现放射增敏。

本文引用的文献

1
Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma.基于皮肤黑色素瘤细胞溶解活性鉴定新型分子治疗靶点及其潜在的预后生物标志物
Front Oncol. 2022 Mar 8;12:844666. doi: 10.3389/fonc.2022.844666. eCollection 2022.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.
Asian J Pharm Sci. 2024 Apr;19(2):100903. doi: 10.1016/j.ajps.2024.100903. Epub 2024 Mar 10.
4
Multifunctional Near-Infrared Dye IR-817 Encapsulated in Albumin Nanoparticles for Enhanced Imaging and Photothermal Therapy in Melanoma.多功能近红外染料 IR-817 包封在白蛋白纳米颗粒中,用于增强黑色素瘤的成像和光热治疗。
Int J Nanomedicine. 2023 Sep 4;18:4949-4967. doi: 10.2147/IJN.S425013. eCollection 2023.
5
Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway.线粒体靶向近红外治疗剂通过E2F/细胞周期蛋白/细胞周期蛋白依赖性激酶途径诱导细胞凋亡和细胞周期阻滞来抑制黑色素瘤。
Pharmaceuticals (Basel). 2022 Dec 19;15(12):1589. doi: 10.3390/ph15121589.
黑色素瘤及靶向治疗获得性耐药中的氧化应激相关机制
Antioxidants (Basel). 2021 Dec 3;10(12):1942. doi: 10.3390/antiox10121942.
4
Oxidative Stress and Autophagy as Key Targets in Melanoma Cell Fate.氧化应激和自噬作为黑色素瘤细胞命运的关键靶点
Cancers (Basel). 2021 Nov 18;13(22):5791. doi: 10.3390/cancers13225791.
5
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines.烟酰胺 N-甲基转移酶基因沉默增强黑素瘤细胞系的化疗敏感性。
Pigment Cell Melanoma Res. 2021 Nov;34(6):1039-1048. doi: 10.1111/pcmr.12993. Epub 2021 May 28.
6
Cepharanthine as a Potential Novel Tumor-Regional Therapy in Treating Cutaneous Melanoma: Altering the Expression of Cathepsin B, Tumor Suppressor Genes and Autophagy-Related Proteins.千金藤素作为一种潜在的新型肿瘤区域治疗药物用于治疗皮肤黑色素瘤:改变组织蛋白酶B、肿瘤抑制基因和自噬相关蛋白的表达
Front Bioeng Biotechnol. 2020 Dec 1;8:601969. doi: 10.3389/fbioe.2020.601969. eCollection 2020.
7
The role of lysosomes in cancer development and progression.溶酶体在癌症发生和发展中的作用。
Cell Biosci. 2020 Nov 18;10(1):131. doi: 10.1186/s13578-020-00489-x.
8
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness.对氧磷酶 2:皮肤癌侵袭性的一个潜在生物标志物。
Eur J Clin Invest. 2021 May;51(5):e13452. doi: 10.1111/eci.13452. Epub 2020 Dec 1.
9
Current State of Target Treatment in BRAF Mutated Melanoma.BRAF 突变型黑色素瘤的靶向治疗现状
Front Mol Biosci. 2020 Jul 14;7:154. doi: 10.3389/fmolb.2020.00154. eCollection 2020.
10
Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance-A Mini Review.靶向溶酶体治疗癌症:克服化疗耐药性的一种有前景的策略——一篇综述短文
Front Oncol. 2020 Jul 9;10:1156. doi: 10.3389/fonc.2020.01156. eCollection 2020.